November 15, 2024

IT security campaign of the four university hospitals in Baden-Württemberg receives award

IT security campaign of the four university hospitals in Baden-Württemberg receives award

Cyberattacks and analog attacks are a serious and ever-increasing threat to hospitals. In 2022, the Dr. Nope campaign at the four university hospitals in Baden-Württemberg demonstrated in a humorous way how employees can protect information and IT tools through their own personal behavior. The information security initiative has now been awarded the Security Prize at the sixth Baden-Württemberg Cyber Security Forum.

How do we handle information inside and outside our organizations? How do we protect information and IT tools through our own personal behavior? These and many other questions were the focus of an information campaign on information security in 2022, which was launched by the four university hospitals in Baden-Württemberg and has now been awarded the Security Prize at the sixth Baden-Württemberg Cyber Security Forum.

At the heart of the campaign was the fictional character Dr. Nope, “the” expert in Baden-Württemberg when it comes to information security. With his help, seven simple, easy-to-remember rules were developed: Things that employees should simply not do in order not to jeopardize information security – their own and that of their patients. The rules – e.g. rule no. 1 “No careless use of emails” – were communicated to employees in a variety of ways, e.g. with the help of posters, table displays, postcards, a landing page and an elaborate video. Tablet displays in the casinos, life-size Dr. Nope figures in the clinics, a hidden object picture, a “tree of decision” and various articles in the internal media rounded off the campaign.

“With the Security Award, we are recognizing lighthouse projects that protect our successful business location,” said Baden-Württemberg’s Minister of the Interior Thomas Strobl at the award ceremony. Together with Minister of Economic Affairs Dr. Nicole Hoffmeister-Kraut, he presented the award to a total of four winners. In addition to the four university hospitals in Baden-Württemberg, Mercedes-AMG GmbH, mindUp Web + Intelligence GmbH and the start-up Whitematics GmbH were also honored.

Original News

Our latest News

discover more
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers

RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers

Heidelberg, Germany, 19.12.2024 – RHEACELL today received approval from the European Medicines Agency (EMA) for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will be conducted at more than 100 sites and is expected to enroll 250 patients, starting enrollment in Europe in Q1 2025. […]

Common cough syrup ingredient shows promise in treating serious lung disease

Common cough syrup ingredient shows promise in treating serious lung disease

EMBL scientists discover that an FDA-approved, over-the-counter cough syrup ingredient has potential to treat fibrotic lung disease. Summary A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.  Scientists from EMBL Heidelberg were part of a […]

Antibody that Neutralizes Inhibitory Factors Involved in Nerve Regeneration Leads to Enhanced Motor Function after Acute Spinal Cord Injury

Antibody that Neutralizes Inhibitory Factors Involved in Nerve Regeneration Leads to Enhanced Motor Function after Acute Spinal Cord Injury

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, Switzerland, the Czech Republic and Spain have investigated this with promising results. For the first time, it was possible to identify patient groups that displayed a clinically relevant treatment effect. A follow-up study will start in December […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp